Cargando…

Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa

BACKGROUND: Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) programmes in sub-Saharan Africa have high mortality risk. However, published data are contradictory as to whether TB is a risk factor for mortality that is independent of CD4 cell counts and other pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Ankur, Wood, Robin, Kaplan, Richard, Bekker, Linda-Gail, Lawn, Stephen D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572168/ https://www.ncbi.nlm.nih.gov/pubmed/23418463 http://dx.doi.org/10.1371/journal.pone.0055824

Ejemplares similares

Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community
por: Gupta, Ankur, et al.
Publicado: (2012)

The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study
por: Kerkhoff, Andrew D, et al.
Publicado: (2015)

Temporal Association Between Incident Tuberculosis and Poor Virological Outcomes in a South African Antiretroviral Treatment Service
por: Gupta-Wright, Ankur, et al.
Publicado: (2013)

Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa
por: Kerkhoff, Andrew D, et al.
Publicado: (2014)

Rates of Switching Antiretroviral Drugs in a Primary Care Service in South Africa before and after Introduction of Tenofovir
por: Njuguna, Christine, et al.
Publicado: (2013)

Identification of losses to follow-up in a community-based antiretroviral therapy clinic in South Africa using a computerized pharmacy tracking system
por: Nglazi, Mweete D, et al.
Publicado: (2010)

Increasing Transfers-Out from an Antiretroviral Treatment Service in South Africa: Patient Characteristics and Rates of Virological Non-Suppression
por: Nglazi, Mweete D., et al.
Publicado: (2013)

Linkage to HIV Care and Antiretroviral Therapy in Cape Town, South Africa
por: Kranzer, Katharina, et al.
Publicado: (2010)

Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa
por: Nglazi, Mweete D, et al.
Publicado: (2012)

The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study
por: Nglazi, Mweete D., et al.
Publicado: (2015)

CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa
por: Lawn, Stephen D, et al.
Publicado: (2006)

Burden of New and Recurrent Tuberculosis in a Major South African City Stratified by Age and HIV-Status
por: Wood, Robin, et al.
Publicado: (2011)

Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa
por: Badri, Motasim, et al.
Publicado: (2006)

Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township
por: Lawn, Stephen D, et al.
Publicado: (2011)

Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa
por: Lawn, Stephen D, et al.
Publicado: (2007)

Indoor Social Networks in a South African Township: Potential Contribution of Location to Tuberculosis Transmission
por: Wood, Robin, et al.
Publicado: (2012)

Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study
por: Kranzer, Katharina, et al.
Publicado: (2012)

Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study
por: Lawn, Stephen D., et al.
Publicado: (2011)

Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy
por: Orrell, Catherine, et al.
Publicado: (2011)

Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa
por: Lawn, Stephen D, et al.
Publicado: (2007)

Antiretroviral Treatment as Prevention: Impact of the ‘Test and Treat’ Strategy on the Tuberculosis Epidemic
por: Wood, Robin, et al.
Publicado: (2011)

Implementation of community-based adherence clubs for stable antiretroviral therapy patients in Cape Town, South Africa
por: Grimsrud, Anna, et al.
Publicado: (2015)

Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis
por: Gupta-Wright, Ankur, et al.
Publicado: (2016)

Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa
por: Kerkhoff, Andrew D., et al.
Publicado: (2020)

High Prevalence of Self-Reported Undiagnosed HIV despite High Coverage of HIV Testing: A Cross-Sectional Population Based Sero-Survey in South Africa
por: Kranzer, Katharina, et al.
Publicado: (2011)

Twelve-year mortality in adults initiating antiretroviral therapy in South Africa
por: Cornell, Morna, et al.
Publicado: (2017)

Tuberculosis in Antiretroviral Treatment Services in Resource-Limited Settings: Addressing the Challenges of Screening and Diagnosis
por: Lawn, Stephen D., et al.
Publicado: (2011)

Ocular parameters of biological ageing in HIV-infected individuals in South Africa: Relationship with chronological age and systemic biomarkers of ageing()
por: Pathai, Sophia, et al.
Publicado: (2013)

Antiretroviral Therapy for Control of the HIV-associated Tuberculosis Epidemic in Resource-Limited Settings
por: Lawn, Stephen D., et al.
Publicado: (2009)

Financing equitable access to antiretroviral treatment in South Africa
por: Cleary, Susan, et al.
Publicado: (2010)

Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria
por: Wood, Robin, et al.
Publicado: (2012)

The Survival Benefits of Antiretroviral Therapy in South Africa
por: April, Michael D., et al.
Publicado: (2014)

Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis
por: Kranzer, Katharina, et al.
Publicado: (2010)

Antiretroviral Treatment Cohort Analysis Using Time-Updated CD4 Counts: Assessment of Bias with Different Analytic Methods
por: Kranzer, Katharina, et al.
Publicado: (2011)

Accelerated biological ageing in HIV-infected individuals in South Africa: a case–control study
por: Pathai, Sophia, et al.
Publicado: (2013)

HIV prevalence and determinants of loss-to-follow-up in adolescents and young adults with tuberculosis in Cape Town
por: Mulongeni, Pancho, et al.
Publicado: (2019)

Retinal Nerve Fibre Layer Thickness and Contrast Sensitivity in HIV-Infected Individuals in South Africa: A Case-Control Study
por: Pathai, Sophia, et al.
Publicado: (2013)

Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study
por: Estill, Janne, et al.
Publicado: (2013)

Lessons from two SARS-CoV-2 waves in South Africa
por: Bekker, Linda-Gail, et al.
Publicado: (2021)

Increased Access to Antiretroviral Therapy Is Associated with Reduced Maternal Mortality in Johannesburg, South Africa: An Audit from 2003-2012
por: Black, Vivian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rgvtr17l0ueipmgofvt6ikklid